findmyKOL

Roberto Benzo, MD

Enriched profile

Consultant, Pulmonary Medicine; Mayo Clinic College of Medicine and Science faculty · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Scottsdale, AZ · West · United StatesSpecialtyPulmonary DiseaseFocusChronic Obstructive Pulmonary Disease (COPD) Research+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceNone verifiedPaymentsNone reportedNIH funding2022–2025Why? →

Roberto Benzo is Consultant, Pulmonary Medicine; Mayo Clinic College of Medicine and Science faculty at Mayo Clinic. OpenAlex indexes 74 publications with 2,114 citations (h-index 28); ClinicalTrials.gov lists 23 registered studies with this person as an investigator.

Data verified 10 Oct 2026

Overview

Updated 15 Oct 2026

Roberto Benzo, MD, is Consultant, Pulmonary Medicine at Mayo Clinic. The public record shows 74 publications with 2,114 citations (h-index 28), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Physical Activity and Health, Cardiovascular and exercise physiology. It also documents an investigator role on 23 registered clinical trials, 2 NIH-funded awards (2022–2025).

  • Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
  • 23 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
COPD16 trialsLung Diseases10 trialsEmphysema5 trialsLung Cancer (NSCLC/SCLC)2 trialsPostoperative Complications1 trialTobacco Use Disorder1 trialDyspnea1 trialFatigue1 trialObesity1 trialSleep Apnea, Obstructive1 trialApnea1 trialBronchiectasis1 trialCarcinoma, Small Cell1 trialGastroesophageal Cancer1 trialEsophageal Neoplasms1 trialAsthma

Research focus

OpenAlex concept fingerprint
Chronic Obstructive Pulmonary Disease (COPD) ResearchPhysical Activity and HealthCardiovascular and exercise physiologyNursing care and researchAsthma and respiratory diseases

Works with

trial sponsors and companies reporting payments
Mayo ClinicClinical trials23Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
74publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

2,114citations

Total citations across indexed works.

28h-index

Hirsch index (OpenAlex). i10-index 41.

Clinical & industry

trials, payments and federal funding
23clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2022–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    51.7%
    Corticosteroid31.3%
    Trelegy Ellipta57%Breo Ellipta13%Fluticasone Propionate13%Budesonide-Formoterol Fumarate11%Dulera6%
    Part D<11 patients
    Leukotriene Receptor Antagonist6.5%
    Montelukast Sodium100%
    Part D≥14 patients

    + 3 more classes in this area

  • Anti-infectives

    40.2%
    Macrolide Antimicrobial38.2%
    Azithromycin100%
    Part D≥39 patients
    Penicillins with extended spectrum1.9%
    Amoxicillin-Clavulanate Potass100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    8.1%
    Corticosteroid8.1%
    Prednisone100%
    Part D≥16 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 15 Oct 2026

2 NIH research awards on record, funded 2022–2025 per NIH RePORTER. The latest:

Congress activity

Updated 15 Oct 2026

2 congress contributions (2012–2024) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Paul J. Novotny16Cassie C. Kennedy10Frank C. Sciurba9Matthew M. Clark7Jennifer L. Ridgeway6Craig Karpman5Maria V. Benzo5Zachary S. DePew5Emma Fortune5Nathan K. LeBrasseur4Robert A. Wise4Stephanie J. Zawada4Moein Enayati4Louis J. Faust4Beatriz Abascal-Bolado4Mary O. Whipple3David Donaire-González3Selina Dürr3Malcolm Kohler3Rafael Mesquita3Janae L. Kirsch3William R. Midthun3Johanna P Hoult3Frank W.J.M. Smeenk3Nídia Aparecida Hernandes3Nicholas S Hopkinson3Barbara Vagaggini3Gabriele Spina3Martijn A. Spruit3Richard W. Costello3William A. Slivka3Ruth Tal‐Singer3MARIA BENZO3Kylie Hill3Judith García‐Aymerich3Alanna M. Chamberlain3Sally J. Singh3Zoe Jane McKeough3Diana Jarreta3Benjamin Waschki3

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    newsnetwork.mayoclinic.org/discussion/mayo-clinic-radio-copd-mindfulness-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsnetwork.mayoclinic.org ↗
  • Other

    thoracic.org/about/ats-podcasts/self-management-in-copd-and-chronic-lung-disease.php

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thoracic.org ↗
  • Spotify

    buzzsprout.com/1396861/5788930-mindfulness-and-coaching-for-chronic-disease

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →buzzsprout.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗

Secondary affiliations

appointments beyond the home institution
  • Founding Director

    Mindful Breathing Laboratory, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.